Human Metabolome Technologies, Inc.

6090・Standard Market・Services

Official website

Human Metabolome Technologies, Inc.

6090・Standard Market・Services

Official website

Human Metabolome Technologies, Inc.6090

Reference Indicators

Market Cap

35¥100M

P/E (Forecast)

19.1x

P/B

1.8x

Dividend Yield (Forecast)

3.01%

ROE

10.8%

EV/EBITDA

6.8x

Financial Summary

Unit: ¥M

Item	2022Jun 2022	2023Jun 2023	2024Jun 2024	2025Jun 2025	2026Jun 2026
Net Sales	1,223	1,299	1,345	1,455	1,421
Cost of Sales	383	439	476	533	553
Gross Profit	840	859	869	921	868
SG&A Expenses	648	648	649	672	658
Operating Income	191	210	220	249	209
Non-operating Income	64	24	23	4	3
Non-operating Expenses	2	2	2	13	6
Ordinary Income	253	232	241	240	206
Extraordinary Income	9	4	21	35	17
Extraordinary Losses	0	—	0	7	—
Pre-tax Income	261	237	261	269	224
Income Taxes	-5	-48	18	13	24
Net Income	267	285	243	256	200
EBITDA	256	291	306	353	321
Gross Margin	68.7%	66.2%	64.6%	63.3%	61.1%
Operating Margin	15.6%	16.2%	16.4%	17.1%	14.8%
ROA	12.9%	12.5%	9.3%	10.8%	8.8%
ROE	20.8%	18.4%	13.5%	13.6%	10.8%

Segment Performance

Unit: ¥M

2025

Segment	Net Sales	Operating Income	Operating Margin
先端研究開発支援事業	1,143	184	16.1%
ヘルスケア・ソリューション事業	311	64	20.6%